13-91354178-TTTAG-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NR_027350.1(MIR17HG):n.4623_4626del variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000637 in 152,302 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00064 ( 0 hom., cov: 32)
Consequence
MIR17HG
NR_027350.1 non_coding_transcript_exon
NR_027350.1 non_coding_transcript_exon
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.67
Genes affected
MIR17HG (HGNC:23564): (miR-17-92a-1 cluster host gene) This gene is the host gene for the MIR17-92 cluster, a group of at least six microRNAs (miRNAs) that may be involved in cell survival, proliferation, differentiation, and angiogenesis. Amplification of this gene has been found in several lymphomas and solid tumors. Two non-protein coding transcript variants have been found for this host gene, but only the longest is a polycistronic transcript containing the MIR17-92 cluster. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 13-91354178-TTTAG-T is Benign according to our data. Variant chr13-91354178-TTTAG-T is described in ClinVar as [Likely_benign]. Clinvar id is 3355368.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 97 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIR17HG | NR_027350.1 | n.4623_4626del | non_coding_transcript_exon_variant | 2/2 | ||||
MIR17HG | NR_027349.1 | n.532_535del | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIR17HG | ENST00000710422.1 | n.407+3954_407+3957del | intron_variant, non_coding_transcript_variant | |||||||
ENST00000710739.1 | n.1036-1334_1036-1331del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
97
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.000637 AC: 97AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000591 AC XY: 44AN XY: 74462
GnomAD4 genome
AF:
AC:
97
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
44
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MIR17HG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 04, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at